C93.12
Chronic myelomonocytic leukemia, in relapse
Clinical Classification Guidelines
Medical Intelligence & Overview
Chronic myelomonocytic leukemia (CMML) is a rare form of blood cancer that affects the bone marrow's ability to produce healthy blood cells. When CMML returns after treatment, it is called a relapse. Understanding this condition can help patients and their families better comprehend their diagnosis, treatment options, and what to expect moving forward.
Causes & Symptoms
Clinical Causes: Mutations in certain genes that control blood cell growth Genetic predisposition or inherited factors Previous exposure to radiation or chemotherapy Age-related changes in bone marrow function Environmental toxins or chemicals
Key Symptoms: Persistent fatigue or weakness Unintended weight loss Fever or recurrent infections Easy bruising or bleeding Swollen or painless lymph nodes Pain or fullness below the ribs due to enlarged spleen or liver Shortness of breath or dizziness
Diagnostic & Treatment
Diagnosis Path: Diagnosis of relapsed CMML involves a combination of blood tests, bone marrow examinations, and genetic studies. These include:
Treatment Protocols: Managing relapsed CMML requires a multidisciplinary approach. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is C93.12 a billable ICD-10 code?
Yes, C93.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C93.12?
Clinical documentation must specify the nature of Chronic myelomonocytic leukemia, in relapse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference